Ingrezza — Cigna
Chorea associated with Huntington’s disease
Initial criteria
- Patient age ≥ 18 years
- Diagnosis of Huntington’s disease is confirmed by genetic testing (e.g., expanded HTT CAG repeat sequence of at least 36)
- Medication is prescribed by or in consultation with a neurologist
Approval duration
1 year